Context Therapeutics Inc (CNTX): What a gift in the AM .90-1.25

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	106
Posts	7819
Boards Moderated	0
Alias Born	09/10/2009

Welsh_Dragon

Re: None

Tuesday, 01/31/2023 9:33:40 AM

Tuesday, January 31, 2023 9:33:40 AM

What a gift in the AM .90-1.25

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent CNTX News

Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 11/06/2024 09:42:41 PM
Context Therapeutics Reports Third Quarter 2024 Operating and Financial Results • GlobeNewswire Inc. • 11/06/2024 09:06:13 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/06/2024 09:02:40 PM
Context Therapeutics to Participate in Upcoming Investor Conferences in November • GlobeNewswire Inc. • 10/23/2024 11:30:00 AM
Context Therapeutics Announces Poster Presentation at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual Meeting • GlobeNewswire Inc. • 10/16/2024 11:30:23 AM
Form 8-K - Current report • Edgar (US Regulatory) • 09/23/2024 11:33:19 AM
Form 8-K - Current report • Edgar (US Regulatory) • 09/17/2024 08:22:23 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/04/2024 11:34:25 AM
Context Therapeutics Appoints Dr. Karen Smith and Dr. Luke Walker to Board of Directors • GlobeNewswire Inc. • 09/04/2024 11:30:47 AM
Context Therapeutics Reports Second Quarter 2024 Operating and Financial Results • GlobeNewswire Inc. • 08/07/2024 08:17:13 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/07/2024 08:07:48 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/01/2024 09:18:30 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/01/2024 09:15:17 PM
Context Therapeutics Appoints Chief Medical Officer and Vice President of Clinical Operations • GlobeNewswire Inc. • 08/01/2024 11:30:00 AM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 07/24/2024 09:07:18 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 07/24/2024 08:55:48 PM
Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 07/12/2024 08:04:41 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/10/2024 11:33:59 AM
Context Therapeutics Acquires Phase 1-ready T cell Engager CT-95 • GlobeNewswire Inc. • 07/10/2024 11:30:00 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/14/2024 11:50:14 AM
Form 8-K - Current report • Edgar (US Regulatory) • 06/14/2024 11:34:52 AM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 06/03/2024 04:15:21 AM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/31/2024 08:06:51 PM
Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 05/24/2024 08:15:19 PM

More CNTX News

InvestorsHub NewsWire

SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM

DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM

SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM

Rainmaker Worldwide Inc. (OTC: RAKR) Announces Successful Implementation of 1.6 Million Liter Per Day Wastewater Treatment Project in Iraq • RAKR • Nov 7, 2024 8:30 AM

SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance • SBC • Nov 7, 2024 7:00 AM

VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover